[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100534909":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":37,"responsibleParty":82,"collaborators":84,"id":87,"slug":88,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":21,"eligibilityCriteria":92,"healthyVolunteers":89,"sex":93,"minAge":94,"maxAge":95,"enrollmentInfo":96,"targetDuration":24,"studyType":99,"phases":100,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":40,"whyStopped":24,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"National Cancer Centre, Singapore","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Regular screening with needs-guided palliative care treatments","EXPERIMENTAL","The patient continues to receive clinical care from the cardiologist, as well as palliative care treatments that are based upon his\u002Fher reported distress and concerns.",[13],"Other: TIER-HF-PC",{"label":15,"type":6,"description":16,"interventionNames":17},"Usual Care","Patient is referred by cardiologist to palliative care.",[18],"Other: Usual Care",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"TIER-HF-PC","The patient will be assigned to one of the three levels of care which is determined by the results given by Distress Thermometer (DT) and the Integrated Palliative Care Outcome Scale (IPOS).",[9],null,{"type":6,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Patient continues on clinical care by his\u002Fher cardiologist. If the cardiologist picks up their symptoms or other concerns, he\u002For can be referred to a specialist palliative care physician by the cardiologist.",[15],[29],{"name":30,"affiliation":5,"role":31},"Dr Shirlyn Neo, MBBS, MRCP (UK), MMed, FAMS","PRINCIPAL_INVESTIGATOR",[33],{"name":30,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","+65 63065838","shirlyn.neo.h.s@singhealth.com.sg",[38,55,65,75],{"facility":39,"status":40,"city":41,"state":24,"zip":42,"country":41,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"National Heart Centre Singapore","RECRUITING","Singapore","169609","SG",{"type":45,"coordinates":46},"Point",[47,48],103.85007,1.28967,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":53,"phoneExt":24,"email":54},"Dr David KL Sim, MBBS, MMed, MRCP(UK)","+6567048895","david.sim@singhealth.com.sg",{"facility":56,"status":40,"city":41,"state":24,"zip":57,"country":41,"countryCode":43,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"Sengkang General Hospital","544886",{"type":45,"coordinates":59},[47,48],{"lat":48,"lon":47},[62],{"name":63,"role":34,"phone":24,"phoneExt":24,"email":64},"Dr Lionel KY See, MD, MRCP (UK), MMed (Int Med)","lionel.see.k.y@singhealth.com.sg",{"facility":66,"status":40,"city":41,"state":24,"zip":67,"country":41,"countryCode":43,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"Khoo Teck Puat Hospital","768828",{"type":45,"coordinates":69},[47,48],{"lat":48,"lon":47},[72],{"name":73,"role":34,"phone":24,"phoneExt":24,"email":74},"Dr Laurence LC Tan, MBBS, MMed, FAMS","tan.laurence.lc@ktph.com.sg",{"facility":5,"status":40,"city":41,"state":24,"zip":24,"country":41,"countryCode":43,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},{"type":45,"coordinates":77},[47,48],{"lat":48,"lon":47},[80],{"name":30,"role":34,"phone":81,"phoneExt":24,"email":36},"+6563065838",{"type":83,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[85,86],{"name":39,"class":6},{"name":66,"class":6},"100534909","timely-interventions-to-enable-and-reach-patients-with-heart-failure-and-their-caregivers-with-palliative-care-100534909",false,"NCT06244953","Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care","Inclusion Criteria:\n\n* Patients:\n\n  1. 21 years or older and\n  2. able to communicate in English or Chinese and\n  3. be of stage C or D heart failure, as defined by American College of Cardiology\u002FAmerican Heart Association (ACC\u002FAHA) classification system and\n  4. have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and\n  5. be deemed by their cardiologist's clinical judgement to have an expected prognosis of at least 6 months survival, and\n  6. have had a heart failure related hospitalization event (e.g. symptomatic decompensated heart failure) within 6 months prior to recruitment and\n  7. have a phone that allows telecommunication.\n* Caregivers must meet all the following inclusion criteria to be eligible for the study :\n\n  * direct, unpaid, family caregiver of the patient;\n  * self-reported by the patient to be the main person to be either:\n  * responsible for up to 4 hours a day of caregiving tasks\n  * and\u002For decision maker\u002Fspokesperson with the medical team\n  * Caregiver may or may not live in the same residence as the patient.\n  * Caregivers must be 21 years and above.\n  * Able to communicate in English or Chinese.\n\nExclusion Criteria:\n\n* Patients:\n\n  1. have cognitive impairment (e.g., dementia)\n  2. have severe, untreated, active mental illness (e.g., major depressive disorder)\n  3. have ventricular assist device implant.\n  4. have non-reversible hearing or visual loss or\n  5. are active drug abuser or\n  6. already known to a palliative care service.\n* Caregivers who meet any of the exclusion criteria at baseline will be ineligible for the study:\n\n  * have cognitive impairment (e.g., dementia) or\n  * have severe, untreated, active mental illness (e.g., major depressive disorder)\n  * have non-reversible hearing or visual loss.\n  * are active drug abuser or\n  * are a domestic helper for the patient","ALL","21 Years","99 Years",{"count":97,"type":98},240,"ESTIMATED","INTERVENTIONAL",[101],"NA","There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.",[104],"Heart Failure",[106,107,108,109,110,21],"Palliative care","Patients","Caregivers","Distress thermometer (DT)","Integrated Palliative Care Outcome Scale (IPOS)","2025-04-06",{"date":113,"type":114},"2025-04-08","ACTUAL",{"date":116,"type":114},"2024-08-14",{"date":118,"type":98},"2027-10-31",{"name":5,"class":6},4]